Cirrhotic cardiomyopathy: is there any correlation between the stage of cardiac impairment and the severity of liver disease?

References

• Kowalski HJ, Abelmann WH. The cardiac output at rest in Laennec’s cirrhosis. J Clin Invest. 1953;32(10):1–8.
   Web of Science ®Google Scholar
• Rabie RN, Cazzaniga M, Salerno F, et al. The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt. Am J Gastroenterol. 2009;104(10):2458–2466.
   Web of Science ®Google Scholar
• Cazzaniga M, Salerno F, Pagnozzi G, et al. Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt. Gut. 2007;56(6):869–875.
   PubMed Web of Science ®Google Scholar
• Ruíz-del-Árbol L, Achécar L, Serradilla R, et al. Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine. Hepatolbaltim Md. 2013;58(5):1732–1741.
   PubMed Web of Science ®Google Scholar
• Møller S, Henriksen JH. Cardiovascular complications of cirrhosis. Gut. 2008;57(2):268–278.
   PubMed Web of Science ®Google Scholar
• Guevara M, Bru C, Ginès P, et al. Increased cerebrovascular resistance in cirrhotic patients with ascites. Hepatolbaltim Md. 1998;28(1):39–44.
   Google Scholar
• Maroto A, Ginès P, Arroyo V, et al. Brachial and femoral artery blood flow in cirrhosis: relationship to kidney dysfunction. Hepatolbaltim Md. 1993;17(5):788–793.
   Google Scholar
• Herring N, Danson EJF, Paterson DJ. Cholinergic control of heart rate by nitric oxide is site specific. News Physiolsciint J Physiol Prod Jointly Int Union Physiolsci Am Physiol Soc. 2002;17:202–206.
   Google Scholar
• Anselmi A, Gaudino M, Baldi A, et al. Role of apoptosis in pressure-overload cardiomyopathy. J Cardiovasc Med Hagerstown Md. 2008;9(3):227–232.
   Web of Science ®Google Scholar
• Szabó Z, Harangi M, Lörincz I, et al. Effect of hyperlipidemia on QT dispersion in patients without ischemic heart disease. Can J Cardiol. 2005;21(10):847–850.
   Web of Science ®Google Scholar
• Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233–270.
   PubMed Web of Science ®Google Scholar
• Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17:1321–1360.
   PubMed Web of Science ®Google Scholar
• Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Socechocardiogr off Publ Am Socechocardiogr. 2016;29(4):277–314.
   PubMed Web of Science ®Google Scholar
• Nazar A, Guevara M, Sitges M, et al. LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction. J Hepatol. 2013;58(1):51–57.
   PubMed Web of Science ®Google Scholar
• Sampaio F, Pimenta J, Bettencourt N, et al. Systolic and diastolic dysfunction in cirrhosis: a tissue-Doppler and speckle tracking echocardiography study. Liver Intoff J Intassoc Study Liver. 2013;33(8):1158–1165.
   Web of Science ®Google Scholar
• Morris DA, Boldt L-H, Eichstädt H, et al. Myocardial systolic and diastolic performance derived by 2-dimensional speckle tracking echocardiography in heart failure with normal left ventricular ejection fraction. Circ Heart Fail. 2012;5(5):610–620.
   Web of Science ®Google Scholar
• Silvestre OM, Bacal F, De Souza Ramos D, et al. Impact of the severity of end-stage liver disease in cardiac structure and function. Ann Hepatol. 2013;12(1):85–91.
   Web of Science ®Google Scholar
• Merli M, Calicchia A, Ruffa A, et al. Cardiac dysfunction in cirrhosis is not associated with the severity of liver disease. Eur J Intern Med. 2013;24(2):172–176.
   Web of Science ®Google Scholar
• Fattouh AM, El-Shabrawi MH, Mahmoud EH, et al. Evaluation of cardiac functions of cirrhotic children using serum brain natriuretic peptide and tissue Doppler imaging. Ann Pediatrcardiol. 2016;9(1):22–28.
   Google Scholar
• Li X, Yu S, Li L, et al. Cirrhosis-related changes in left ventricular function and correlation with the model for end-stage liver disease score. Int J Clinexp Med. 2014;7(12):5751–5757.
   Google Scholar
• Salari A, Shafaghi A, Ofoghi M, et al. Diastolic dysfunction and severity of cirrhosis in nonalcoholic cirrhotic patients. Int J Hepatol. 2013;2013:1–6.]
   Google Scholar
• Valeriano V, Funaro S, Lionetti R, et al. Modification of cardiac function in cirrhotic patients with and without ascites. Am J Gastroenterol. 2000;95(11):3200–3205.
   Web of Science ®Google Scholar
• Papastergiou V, Skorda L, Lisgos P, et al. Ultrasonographic prevalence and factors predicting left ventricular diastolic dysfunction in patients with liver cirrhosis: is there a correlation between the grade of diastolic dysfunction and the grade of liver disease? ScientificWorldJournal. 2012;2012:1–6.
   Google Scholar
• Thomas JD, Badano LP. EACVI-ASE-industry initiative to standardize deformation imaging: a brief update from the co-chairs. Eur Heart J Cardiovasc Imaging. 2013;14(11):1039–1040.
   Web of Science ®Google Scholar
• Myers RP, Lee SS. Cirrhotic cardiomyopathy and liver transplantation. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2000;6(4 Suppl 1):S44–S52.
   Google Scholar
• Krag A, Bendtsen F, Henriksen JH, et al. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut. 2010;59(1):105–110.
   PubMed Web of Science ®Google Scholar
• Ruiz-del-Arbol L, Monescillo A, Arocena C, et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatolbaltim Md. 2005;42(2):439–447.
   PubMed Web of Science ®Google Scholar
• Pozzi M, Carugo S, Boari G, et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatolbaltim Md. 1997;26(5):1131–1137.
   PubMed Web of Science ®Google Scholar
• Torregrosa M, Aguadé S, Dos L, et al. Cardiac alterations in cirrhosis: reversibility after liver transplantation. J Hepatol. 2005;42(1):68–74.
   PubMed Web of Science ®Google Scholar
• Albillos A, De La Hera A, González M, et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatolbaltim Md. 2003;37(1):208–217.
   PubMed Web of Science ®Google Scholar
• Zambruni A, Trevisani F, Di Micoli A, et al. Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. J Hepatol. 2008;48(3):415–421.
   PubMed Web of Science ®Google Scholar
• Meyer JS, Mehdirad A, Salem BI, et al. Sudden arrhythmia death syndrome: importance of the long QT syndrome. Am Fam Physician. 2003;68(3):483–488.
   Web of Science ®Google Scholar